ClinicalTrials.gg
CompletedNCT07860099Updated Oct 6, 2026

The Effect of the Cold Needle Technique on Pain and Patient Satisfaction Levels During Intramuscular Injection Administered to the Ventrogluteal Site

An interventional study of Cold Needle Technique and Standard Intramuscular Injection in Injection Site Pain, sponsored by Bezmialem Vakif University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-06.

Sponsored by Bezmialem Vakif University · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Registered 1 year 2 months after the study started (first participant enrolled Jul 2025, registered Sep 2026).
Updated Oct 6, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
78
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 10 studies in Pain by Bezmialem Vakif University — 3 open to participants now, 3 under way, none of them phase 3. Pain · Bezmialem Vakif University.

Started
2025
with 2 others
No phase
9 of 10
3 open now
Registered
10th of 10
by date

Among the 10 studies in Pain by Bezmialem Vakif University, this one is one of 3 that started in 2025, is one of 9 with no phase, and was the 10th registered.

Pain

10,076 studies on the registry are indexed under Pain; 1,648 are open to participants now.

Browse Pain studies →

Open to participants now

3 of the 10 studies in Pain by Bezmialem Vakif University are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 3 open studies →

Where they have run

Who these studies take

Of the 930 Pain studies recruiting now, 384 (41%) set no upper age limit and 434 (47%) stop at 75 or younger; 146 take children under 18; 220 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 10 studies in Pain by Bezmialem Vakif University, or all of them as a file.
02

Study summary

This randomized controlled trial aims to evaluate the effect of the cold needle technique on pain and patient satisfaction during intramuscular injections administered to the ventrogluteal site.

The study was conducted in the internal medicine clinics of Prof. Dr. Cemil Taşçıoğlu City Hospital in Istanbul, Türkiye. A total of 78 adult patients receiving intramuscular vitamin B12 injections as part of their prescribed treatment participated in the study.

Participants were randomly assigned to an intervention group (n=40) or a control group (n=38). The intervention group received intramuscular injections using a cooled needle, while the control group received injections using the standard technique. Only the injection needle was cooled; the medication was not cooled.

Pain intensity and patient satisfaction were assessed after the injection using Visual Analog Scales (VAS).

The study aims to determine whether the cold needle technique reduces injection-related pain and improves patient satisfaction compared with the standard intramuscular injection technique.

Read the detailed description

This study was designed as a randomized controlled trial to investigate the effects of the cold needle technique on pain intensity and patient satisfaction during intramuscular injections administered to the ventrogluteal site.

The study included 78 adult patients who were receiving intramuscular vitamin B12 (cyanocobalamin) injections as part of their prescribed treatment in the internal medicine clinics of Prof. Dr. Cemil Taşçıoğlu City Hospital in Istanbul, Türkiye.

Participants were randomly allocated to two groups: an intervention group consisting of 40 patients and a control group consisting of 38 patients.

In the intervention group, sterile injection needles were cooled in an insulated container containing ice packs. The temperature was monitored using a thermometer. Immediately before the injection, the cooled needle was removed from its sterile packaging and attached to the syringe under aseptic conditions. Only the needle was cooled; the medication and syringe were not refrigerated.

In the control group, intramuscular injections were administered using the standard technique without cooling the needle.

All injections were administered to the ventrogluteal site by the same researcher. The injection procedure was otherwise identical in both groups.

Following the injection, participants assessed their pain intensity and satisfaction using Visual Analog Scales (VAS), with scores ranging from 0 to 10.

The primary outcome was injection-related pain intensity, and the secondary outcome was patient satisfaction.

03

Conditions studied

  • Injection Site Pain

Keywords

  • Cold needle technique
  • Intramuscular injection
  • Ventrogluteal site
  • Pain intensity
  • Patient satisfaction
  • Randomized controlled trial
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged 18 years or older.
  • Receiving a prescribed intramuscular vitamin B12 injection.
  • No cognitive impairment.
  • Able to communicate effectively.
  • Willing to participate in the study and provide .

Exclusion criteria

Exclusion Criteria:

  • Presence of a skin disease or infection at the injection site.
  • Diagnosis of a neurological or psychiatric disorder.
  • History of opioid use that may affect pain perception.
  • Diagnosis of diabetes mellitus.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
78 participants (actual)

Study arms

  • Experimental
    Cold Needle Technique

    Participants in this group (n=40) received intramuscular vitamin B12 injections into the ventrogluteal site using a cooled injection needle. Only the needle was cooled; the medication and syringe were not cooled.

    Procedure: Cold Needle Technique

  • Active comparator
    Standard Injection Technique

    Participants in this group (n=38) received intramuscular vitamin B12 injections into the ventrogluteal site using the standard injection technique without cooling the needle.

    Procedure: Standard Intramuscular Injection

Interventions

  • ProcedureCold Needle Technique

    Sterile injection needles were cooled in an insulated container containing ice packs. Needle temperature was monitored using a thermometer. Immediately before administration, the cooled needle was attached to the syringe under aseptic conditions. Only the needle was cooled; the vitamin B12 medication and syringe were not cooled. The injection was administered into the ventrogluteal site.

  • ProcedureStandard Intramuscular Injection

    Participants received intramuscular vitamin B12 injections into the ventrogluteal site using a standard, non-cooled sterile injection needle. The injection procedure was otherwise identical to that used in the intervention group.

06

What researchers measure

Primary outcomes

  1. Pain Intensity Following Intramuscular Injection

    Pain intensity was assessed using a Visual Analog Scale (VAS) ranging from 0 to 10, where 0 indicates no pain and 10 indicates the worst imaginable pain. Higher scores indicate greater pain intensity.

    Time frame: Immediately after the intramuscular injection

Secondary outcomes

  1. Patient Satisfaction Following Intramuscular Injection

    Patient satisfaction was assessed using a Visual Analog Scale (VAS) ranging from 0 to 10, where 0 indicates complete dissatisfaction and 10 indicates complete satisfaction. Higher scores indicate greater patient satisfaction.

    Time frame: Immediately after the intramuscular injection

07

Study locations

1 site
  • Prof. Dr. Cemil Tascioglu City Hospital
    Istanbul, Istanbul 34384, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: Undecided — A decision regarding the sharing of de-identified individual participant data has not yet been made. Any future data sharing will be considered in accordance with institutional policies, ethical approval, and participant confidentiality requirements.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jul 2025 to primary completion in Jul 2026, 11 months.

Of 3,749 non-industry interventional studies with no phase under Pain, half reached primary completion within 10 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 23. This study's 11 months is close to that.

Counting every sponsor, half of 3,848 studies reached it within 10 months; a quarter within 4 and three quarters within 23.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 22, 2026
First posted
Oct 6, 2026
StartActual
Jul 16, 2025
Primary completionActual
Jul 1, 2026
CompletionActual
Jul 1, 2026
Last update
Oct 6, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 6, 2026
Show all 1 update
  1. Oct 6, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07860099
Responsible party
Merve Ozcan (Master's Student, Bezmialem Vakif University) — Principal investigator
First posted
Oct 6, 2026
Start date
Jul 16, 2025
Primary completion
Jul 1, 2026
Completion
Jul 1, 2026
Last update
Oct 6, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion